Amgen Announces Major Price Cut For Its Breakthrough Cholesterol Drug

By Grace-Marie Turner— The Trump administration continues to work overtime to lower prescription drug costs for consumers.  In response, some pharmaceutical companies have announced rollbacks of price increases, cuts in prices, price freezes, or other ways to improve affordability for patients. In the latest example, Amgen, a leading biologics company, is stepping forward to...

A Surgical Approach To High Prescription Drug Prices

President Trump’s plan to lower prescription drug costs uses a surgeon’s scalpel to address a range of issues, offering nearly 30 policy recommendations to modernize payment policies, weed out counter-productive regulations, improve price transparency, and expand competitive price negotiations. The plan reflects the complexity of the industry and the regulatory system that governs government approval...

Biosimilar Drugs Offer Promise For Drug Price Savings, But Risks Remain

The issue of prescription drug prices continues to top the list of public concerns about health costs, and Congress and the administration are floating possible policy solutions. Solutions to this complex problem will be most effective if they are targeted and geared toward encouraging rather than undermining competition and innovation in the vibrant 21st...